Data from the HART study of Huntexil for HD symptoms now published, but we still need a new, larger trial
Follow-up data from TRACK-HD study proves that we have the tests we need to successfully run drug trials for HD
Success for brain ‘gene therapy’ in Parkinson’s disease – good news for similar treatments being developed in HD
Two clinical trials in Europe and the USA have suggested a new drug, Huntexil, might improve movements in HD. The nex
The one-year report from the TRACK-HD study demonstrates a number of changes in pre-symptomatic HD-mutation carriers